Gastroscopic Evaluation of Gastric Mucosa in Horses Treated With Flunixin Meglumine or High‐Dose Firocoxib: A Descriptive Pilot Study
Veterinary Medicine and Science · 2026
DOI: 10.1002/vms3.71061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2026. Verfasst von Renato Abrantes de Oliveira und 3 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Medicine Institute, Federal University of Pará, Castanhal, Pará, Brazil. Hauptthemen laut MEDLINE: 4-Butyrolactone, Gastric Mucosa, Anti-Inflammatory Agents, Non-Steroidal, Sulfones. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Equine Gastric Ulcer Syndrome (EGUS) is common in horses, and nonsteroidal anti‐inflammatory drugs (NSAIDs) are a known risk factor for gastrointestinal ulceration. Although COX‐2 selective NSAIDs such as firocoxib theoretically offer a better safety profile, endoscopic evidence for their mucosal safety at high off‐label doses is lacking.
Objectives
To compare the effects of label‐dose flunixin meglumine and high‐dose firocoxib on the gastric mucosa of a small selected group of horses using serial gastroscopy and histopathology in a descriptive pilot study.
Methods
Twenty mixed‐breed horses were allocated non‐randomly to control ( n = 10), flunixin meglumine (1.1 mg/kg IM, n = 5), or firocoxib (1.0 mg/kg PO, n = 5) groups, treated once daily for 5 days. Gastroscopic evaluation and histopathological analysis were performed before (Day 1) and after treatment (Day 6).
Results
No glandular disease was observed. Low prevalence of pre‐existing squamous lesions was found in all groups without progression after treatment. Histopathological scores revealed baseline incomparability, with marked cellular infiltrate present only in the flunixin group at Day 1 (60%). Within‐group analyses showed no significant changes between time points ( p > 0.05). The use of NSAIDs effectively resolved lameness.
Conclusions
In this small descriptive pilot study, limited by non‐randomised allocation and small sample size, the study found no detectable short‐term gastric mucosal injury associated with high‐dose firocoxib within the limits of this study. Due to the non‐randomised design, no causal conclusions can be drawn. These hypothesis‐generating findings require confirmation in adequately powered randomised trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterinary Medicine Institute, Federal University of Pará, Castanhal, Pará, Brazil.
- Federal Institute of Tocantins (IFTO), Campus Araguatins, Araguatins, Tocantins, Brazil.
Zitieren
APA
de Oliveira, R. A., Correa, A. D. S., Monteiro, F. D. O., & Teixeira, P. P. M. (2026). Gastroscopic Evaluation of Gastric Mucosa in Horses Treated With Flunixin Meglumine or High‐Dose Firocoxib: A Descriptive Pilot Study. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.71061
Vancouver
de Oliveira RA, Correa ADS, Monteiro FDO, Teixeira PPM. Gastroscopic Evaluation of Gastric Mucosa in Horses Treated With Flunixin Meglumine or High‐Dose Firocoxib: A Descriptive Pilot Study. Veterinary Medicine and Science. 2026. doi:10.1002/vms3.71061
BibTeX
@article{deOliveira2026,
author = {de Oliveira, Renato Abrantes and Correa, Alexandre da Silva and Monteiro, Francisco Décio de Oliveira and Teixeira, Pedro Paulo Maia},
title = {Gastroscopic Evaluation of Gastric Mucosa in Horses Treated With Flunixin Meglumine or High‐Dose Firocoxib: A Descriptive Pilot Study},
journal = {Veterinary Medicine and Science},
year = {2026},
doi = {10.1002/vms3.71061}
}
EUVIMED